Young CA - Search Results

1

Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.

Young CA, Rog DJ, Sharrack B, Tanasescu R, Kalra S, Harrower T, Tennant A, Mills RJ; Trajectories of Outcome in Neurological Conditions-MS Study Group. Young CA, et al. Neurol Sci. 2024 May;45(5):2181-2189. doi: 10.1007/s10072-023-07155-3. Epub 2023 Nov 17. Neurol Sci. 2024. PMID: 37976012 Free PMC article.

2

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

Tubridy N, Behan PO, Capildeo R, Chaudhuri A, Forbes R, Hawkins CP, Hughes RA, Palace J, Sharrack B, Swingler R, Young C, Moseley IF, MacManus DG, Donoghue S, Miller DH. Tubridy N, et al. Neurology. 1999 Aug 11;53(3):466-72. doi: 10.1212/wnl.53.3.466. Neurology. 1999. PMID: 10449105 Clinical Trial.

3

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.

Rog DJ, Nurmikko TJ, Friede T, Young CA. Rog DJ, et al. Among authors: young ca. Neurology. 2005 Sep 27;65(6):812-9. doi: 10.1212/01.wnl.0000176753.45410.8b. Neurology. 2005. PMID: 16186518 Clinical Trial.

4

Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.

Woolmore JA, Stone M, Pye EM, Partridge JM, Boggild M, Young C, Jones PW, Fryer AA, Hawkins CP, Strange RC. Woolmore JA, et al. Mult Scler. 2007 Apr;13(3):369-75. doi: 10.1177/135245850607192. Mult Scler. 2007. PMID: 17439906

5

Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis.

Rog DJ, Nurmikko TJ, Friede T, Young CA. Rog DJ, et al. Among authors: young ca. Clin J Pain. 2007 Jul-Aug;23(6):473-81. doi: 10.1097/AJP.0b013e31805d0c5d. Clin J Pain. 2007. PMID: 17575486

6

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Rog DJ, Nurmikko TJ, Young CA. Rog DJ, et al. Among authors: young ca. Clin Ther. 2007 Sep;29(9):2068-79. doi: 10.1016/j.clinthera.2007.09.013. Clin Ther. 2007. PMID: 18035205 Clinical Trial.

7

Anticholinergics for urinary symptoms in multiple sclerosis.

Nicholas RS, Friede T, Hollis S, Young CA. Nicholas RS, et al. Among authors: young ca. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004193. doi: 10.1002/14651858.CD004193.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160231 Updated. Review.

8

Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS).

Mills RJ, Young CA, Pallant JF, Tennant A. Mills RJ, et al. Among authors: young ca. Health Qual Life Outcomes. 2010 Feb 12;8:22. doi: 10.1186/1477-7525-8-22. Health Qual Life Outcomes. 2010. PMID: 20152031 Free PMC article.

9

The relationship between fatigue and other clinical features of multiple sclerosis.

Mills RJ, Young CA. Mills RJ, et al. Among authors: young ca. Mult Scler. 2011 May;17(5):604-12. doi: 10.1177/1352458510392262. Epub 2010 Dec 6. Mult Scler. 2011. PMID: 21135018

10

Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease.

Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, Talbot K, Tennant A, Young CA. Gibbons CJ, et al. Among authors: young ca. Health Qual Life Outcomes. 2011 Sep 29;9:82. doi: 10.1186/1477-7525-9-82. Health Qual Life Outcomes. 2011. PMID: 21955749 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page